Xencor XNCR
NASDAQ XNCR
$26.60 -0.02 (-0.06%)
As of: Sep 4, 2026 · 1:39 PM EDT

Xencor (XNCR) Profit After Tax (2013 - 2026)

Xencor (XNCR) posted quarterly Profit After Tax of -$130.5 million for Q1 2026, down 169.46% year-over-year from $187.8 million in Q1 2025, and down 1439.59% quarter-over-quarter from -$8.5 million in Q4 2025.

Analysis

Xencor (XNCR) Profit After Tax (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Profit After Tax for 14 consecutive years, with -$130.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Profit After Tax fell 169.46% year-over-year to -$130.5 million; the TTM figure through Mar 2026 stood at -$175.8 million (up 16.04% YoY), while the FY2025 annual figure was -$91.9 million, up 60.81% from the prior year.
  • Profit After Tax slipped to -$130.5 million in Q1 2026 per XNCR's latest filing, from -$8.5 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $18.0 million in Q1 2022 and bottomed at -$130.5 million in Q1 2026.
  • Historically, Profit After Tax has averaged -$38.1 million across 5 years, with a median of -$33.7 million in 2022.
  • Annual changes were most pronounced in 2022 — Profit After Tax jumped 829.83% — and 2023, when it slumped 437.89%.
  • Xencor's Profit After Tax stood at -$12.0 million in 2022, then tumbled by 50.03% to -$18.1 million in 2023, then sank by 147.64% to -$44.7 million in 2024, then surged by 81.06% to -$8.5 million in 2025, then sank by 1439.59% to -$130.5 million in 2026.
  • Business Quant data shows XNCR's Profit After Tax at -$130.5 million in Q1 2026, -$8.5 million in Q4 2025, and -$6.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 472.00 Mn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -644.37 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 81.49 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -16.62 Mn
10 Xencor 2.02 Bn 1.64 Bn - -22.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -22.63 Mn
Mar 31, 2026 -128.92 Mn
Dec 31, 2025 -6.65 Mn
Sep 30, 2025 -6.03 Mn
Jun 30, 2025 -30.92 Mn
Mar 31, 2025 -48.63 Mn
Dec 31, 2024 -48.15 Mn
Sep 30, 2024 -47.44 Mn
Jun 30, 2024 -68.78 Mn
Mar 31, 2024 -74.12 Mn
Dec 31, 2023 -26.31 Mn
Sep 30, 2023 -24.27 Mn
Jun 30, 2023 -20.19 Mn
Mar 31, 2023 -57.44 Mn
Dec 31, 2022 -9.12 Mn
Sep 30, 2022 -33.69 Mn
Jun 30, 2022 -35.80 Mn
Mar 31, 2022 17.98 Mn
Dec 31, 2021 73.06 Mn
Sep 30, 2021 -40.25 Mn